John has a background in cancer research in both academia (Cancer Research UK, University of Glasgow, and University of Cambridge) and pharma (MedImmune). His PhD at the University of Cambridge focused on understanding how tumors become resistant to therapy. He also has experience with multiple start-ups.
Harry leads the development of CCG’s AI tech, cloud architecture, and tumor analysis pipelines. He has a background in cancer bioinformatics, completing his PhD at the University of Oxford and first postdoc at the University of Cambridge with Cancer Research UK. He also brings corporate experience in identifying and developing biomarker-based medical diagnostics.
Evaline oversees the design and delivery of services to cancer care providers and biopharmaceutical customers. She holds a BSE in Chemical and Biological Engineering from Princeton University. Evaline has corporate experience in the petrochemical industry as a process engineer at ExxonMobil and consulting experience within the biotech and nonprofit sectors. She has further experience with engineering and biotechnology through her PhD at the University of Cambridge.
Nirmesh spearheads the clinical research and establishes experimental developments at CCG, sitting at the interface between clinical collaborators and the lab. He brings a deep understanding of the clinical applications of cancer biology, with a background in translational cancer medicine and novel therapeutic development through his PhD at King’s College London and the Institute of Cancer Research.
Hannah is a translational cancer biologist. She has a pharmacology masters degree which included a year of drug discovery with MedImmune and a PhD on the link between type 2 diabetes and colorectal cancer from QMUL. Hannah is passionate about transforming clinical cancer care and will be using her colorectal cancer expertise to help us deliver our product.
Emil is a serial entrepreneur and co-founder of Alchera Technologies with an academic background as a PhD researcher in computational neuroscience at the University of Cambridge. He has extensive knowledge in developing and marketing medical devices and has held roles in finance and numerous technology startups.
Geoffroy is an ML and AI lover. He is a full-stack engineer with experience in deep neural networks and cloud computing architecture. He has prior experience in the Silicon Valley start-up scene, and is now turning his attention to revolutionising cancer genomics.
Henry is a computational biologist with an interest in solving hard problems using cool algorithms. Before joining CCG, Henry completed a PhD in Computational Biology at the University of Cambridge. As part of his PhD he developed a novel method to estimate telomere length in cancer data. At CCG Henry is focused on developing algorithms to assist the detection cancer relapse and building the analysis architecture.
Fergal is using ML to understand the attributes underlying cancer relapse. Fergal’s ML experience comes through his PhD in the Signal Processing group at the University of Cambridge, where he is looking at improving the understanding and performance of convolutional neural networks by applying signal processing methods. He has prior industry experience in Automation and Control and likes to spend time outside his PhD looking at applying ML in fun, different and/or useful ways.
Joe has a masters in Computational Biology from the University of Cambridge. He also has experience in working with NGS data in the hospital and start-up setting. He uses his skills to maintain our variant calling pipelines.
Harry is passionate about the application of engineering for data science data visualisation in medicine. He has previous experience with start-ups and uses his skills to help CCG develop their software.
Belle is a talented science communicator and loves nothing more than conversing about science and its potential. She has a Masters degree in Chemistry from University College London, where she also carried out her PhD in Physical Chemistry. At CCG she uses her skills to develop partnerships and strategic alliances with interested parties all over the world as well as managing CCG’s public engagement strategy.
Olivia has a masters in bioscience enterprise from the University of Cambridge. She is passionate about innovation, start-ups and making an impact in healthcare. Olivia is helping us to develop and maintain partnerships.
Sam is an experienced designer and developer. At CCG he is focusing on shaping the front-end user interface of our software.
Chris has a master's degree in information engineering from Oxford University, where his thesis focused on the intersection of machine learning and optimisation to solve graphical inference problems. At CCG he is working on cutting edge research to advance cancer treatment with machine learning.
Joan is the backbone of our team, she uses her experience in administration to help our multiple projects run smoothly, organises our AI society, assists with our hiring process and anything else she can get her hands on.
Elena has a Masters in Oncology from the QMUL and Barts Cancer Institute, combined with a medical degree and expertise in pharmaceutical industry. Elena is passionate about the potential of genomic technologies to transform cancer care and improve patient outcomes. She brings her entrepreneurial expertise to help to shape CCG’s business development strategy.
Adnan integrates machine learning algorithms into bioinformatics pipelines to deliver a range of analyses, and to help CCG answer novel biological questions. He has a PhD in electronics engineering and professional experience as both a development engineer and a data scientist.
Dominic carries out data synthesis and statistical analyses in order to best interepret the implications for cancer patients. He has a PhD in Statistics and professional experience at the Medical University of Vienna and at AstroZeneca, where he worked on clinical trial design.
Bobbie investigates the patient’s experience of undergoing cancer treatments and patient reception of AI informed treatment strategies. She situates original ethnographic research against public debates concerning genomic data privacy, precision medicine, and the use of AI within health care. Bobbie holds degrees in anthropology and literary criticism from the University of California, Berkeley and the University of Cambridge.
Dàmi has a degree in biotechnology and is currently completing a masters degree in bioinformatics, from Wageningen University & Research.
Jacob has a degree in mathematics from the University of Cambridge and is studying for a masters in Systems Biology. He is using his computational and scientific background to help CCG with their research and development.
Maya has an MSci in Chemisty/Natural Sciences from the University of Cambridge and is currently working on a PhD in molecular evolution. She joins us to help with processing and visualising sequencing data.